InvestorsHub Logo
Followers 11
Posts 690
Boards Moderated 0
Alias Born 11/24/2015

Re: Chemist823 post# 53724

Monday, 02/12/2018 10:54:14 AM

Monday, February 12, 2018 10:54:14 AM

Post# of 108192
Agree - likely affirming data supporting the pending EMA transaction.

Numbers better than current SOC even with advanced stage disease population. Future applications will involve sorting the target population to isolate patients with receptive biomarkers elevating OS to roughly 50-52%.

See Dr. Petit biomarker presentation at June ‘17 Investor Conference. Noteworthy information that has received minimal coverage.

G.B.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News